-Grist Media The proposed Food Security Bill will likely raise the demand for dal across India. While farmers and consumers are against it, the government keeps favouring the agri-industry and importing more and more cheap versions to offset rising inflation. But why won't India produce its own dal anymore? Nowhere are Canada's agricultural production plans tracked more closely than in India's Ministry of Food & Consumer Affairs. As it struggles to meet...
More »SEARCH RESULT
Onion prices at two and a half year high
-PTI NEW DELHI: Onion prices jumped to two and a half year high of Rs 24 per kg due to tight supply and strong Ramzan demand. Wholesale rates at Maharashtra's Lasalgoan, the Asia's biggest wholesale market for onion, soared almost five times higher than levels at the same time last year, stoking fears of retail prices rocketing across the country. Retail prices of onion in Delhi ranged between Rs 30 and 35 per...
More »Direct benefit transfer for LPG a big success, says Moily-Sujay Mehdudia
-The Hindu The scheme has crossed 2.28 million transactions, benefiting 1.25 million LPG households, says Petroleum and Natural Gas Minister Veerappa Moily The ambitious direct benefit transfer (DBT) scheme for domestic LPG cylinder, launched in 18 districts of the country on June 1, has crossed 2.28 million transactions. Indications are that the scheme will be rolled out throughout the country by the year-end. Terming it a big success, Petroleum and Natural Gas Minister...
More »Paying the price-Ramya Kannan
-The Hindu The much-awaited Drug (Prices Control) Order 2013 has disappointed millions of patients, as it lacks a fair formula to fix the price ceiling and leaves important drug classes out of regulation. The result: High out-of-pocket spending on medicines will continue As far as intentions go, the Drug (Prices Control) Order 2013 is aimed at making critical drugs affordable and available to the public, while preserving a rationale for manufacture by...
More »Another bitter pill for patients-Sakthivel Selvaraj
-The Hindu The current market prices are essentially over and above the actual cost of production - a difference that could run from 100 per cent to 5,600 per cent, depending upon various therapeutic categories In a liberalised market economy, do we need price controls on drugs? Policymakers and the pharmaceutical industry do not think so. They believe that price controls are an inefficient tool that distorts resource allocation, squeezes revenue, reduces...
More »